Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A 20-year old female seeking legal abortion was pregnant with gestation in the 16th week as confirmed by ultrasound. Low hemoglobin count of 8.7 g/dl showed iron deficiency which was corrected by transfusion of 2 units of packed cells. Extraamniotic termination of pregnancy was commenced, and 5 mg of prostaglandin E2 (PGE2) in 50 ml of .9% saline was administered. Abortion started 9 hours later; the placenta was removed by curettage, however, severe hemorrhaging and shock ensued. Uterine perforation was ruled out by examination. Hartmann's solution and oxytocin 40 u/l were administered iv. A clotting defect with prolonged prothrombin time, thromboplastin time, and thrombin time was implicated in the excessive bleeding. 3 units of whole blood, 4 units of fresh frozen plasma, and 6 units of platelets were used to treat the coagulopathy. The patient recovered quickly, and clotting tests became normal after 2 days. Follow-up of 1 and 6 weeks showed normal hemoglobin values. PGE2 is routinely used in middle trimester abortions, however, a twentyfold increase in maternal mortality had been reported. Clotting screens are recommended for patients undergoing abortions because of coagulopathy associated with major hemorrhage.
 ...
PMID:Coagulation defect after middle trimester abortion using prostaglandin E2 by the extra-amniotic route. 1234 67